Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Net assets
Net assets on the balance sheet as of December 2023 : $0.50 B
According to Corcept Therapeutics
's latest financial reports the company has $0.50 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.50 B | 0.97% |
| 2022-12-31 | $0.50 B | 33.54% |
| 2021-12-31 | $0.37 B | -28.19% |
| 2020-12-31 | $0.52 B | 40.99% |
| 2019-12-31 | $0.37 B | 34.54% |
| 2018-12-31 | $0.27 B | 44.47% |
| 2017-12-31 | $0.19 B | 361.51% |
| 2016-12-31 | $41.37 M | 123.69% |
| 2015-12-31 | $18.49 M | -645.99% |
| 2014-12-31 | $-3.39 M | -116.12% |
| 2013-12-31 | $21.01 M | -65.98% |
| 2012-12-31 | $61.77 M | 77.48% |
| 2011-12-31 | $34.8 M | 63.84% |
| 2010-12-31 | $21.24 M | -3.84% |
| 2009-12-31 | $22.09 M | 30.67% |
| 2008-12-31 | $16.9 M | 14.75% |
| 2007-12-31 | $14.73 M | 131.67% |
| 2006-12-31 | $6.36 M | -76.08% |
| 2005-12-31 | $26.59 M | -42.12% |
| 2004-12-31 | $45.94 M | -245.99% |
| 2003-12-31 | $-31.48 M | 43.45% |
| 2002-12-31 | $-21.94 M | -198.06% |
| 2001-12-31 | $22.37 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 13,472.79% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 7,745.99% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 17,521.30% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 2,043.99% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 7,327.40% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 3,165.81% | 🇺🇸 USA |
 MannKind Corp MNKD | -$0.25 B | -148.58% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.46 B | -189.79% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 877.21% | 🇺🇸 USA |